MSLN and neoplasm: In a key study published in 2003 by Robinson et al. [16], elevated serum levels of SMRP, correlating with tumor size too, were detected in 84% of patients with MPM (n = 44), 2% of subjects with other cancers of inflammatory lung or pleural conditions (n = 120) and none of 28 controls never exposed to asbestos.